Bottom line
PRHSX vs LHCOX: the short answer
PRHSX (T. Rowe Price Health Sciences Fund, Inc.) and LHCOX (Lord Abbett Health Care Fund) share a meaningful slice of their top holdings — about 47% by weight.
But PRHSX is far broader, holding 279 positions to 61 for LHCOX, so beyond the top names it adds exposure LHCOX doesn't have.
LHCOX is cheaper at 0.68% vs 0.83% — a difference of $15 a year per $10,000 invested.
Over five years, LHCOX returned +4.8% a year vs +4.2% for PRHSX.
Updated Nov 19, 2026
PRHSX vs LHCOX side by side
| PRHSX | LHCOX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | T. Rowe Price | Lord Abbett |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.83% | 0.68% |
| Annual cost per $10k | $83 | $68 |
| 10-yr cost on $10k (prospectus) | $1,025 | $3,267 |
| Max front load | — | 0% |
| 12b-1 fee | — | 0% |
| 1-yr return | +17.7% | +18.1% |
| 5-yr return (annualized) | +4.2% | +4.8% |
| 10-yr return (annualized) | +9.1% | — |
| Best quarter | +23.5% | — |
| Worst quarter | −15.8% | — |
| Net assets (fund) | $11.9B | $8.6M |
| Number of holdings | 279 | 61 |
| Portfolio turnover | 62% | 91% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
10 of PRHSX's top 25 holdings also appear in LHCOX's top 25.
| Holding | PRHSX | LHCOX |
|---|---|---|
| Eli Lilly & Co | 14.28% | 10.40% |
| Johnson & Johnson | 6.63% | 4.96% |
| Unitedhealth Group Inc | 5.99% | 5.39% |
| Gilead Sciences Inc | 2.82% | 3.53% |
| Thermo Fisher Scientific Inc | 2.52% | 2.31% |
| Vertex Pharmaceuticals Inc | 2.28% | 2.24% |
| Natera Inc | 1.44% | 3.60% |
| Guardant Health Inc | 1.23% | 2.61% |
| Cvs Health Corp | 0.94% | 3.33% |
| Protagonist Therapeutics Inc | 0.85% | 1.44% |
Source: SEC Form N-PORT
PRHSX top 10
- Eli Lilly & Co — 14.28%
- Johnson & Johnson — 6.63%
- Unitedhealth Group Inc — 5.99%
- Abbvie Inc — 5.10%
- Merck & Co. Inc. — 4.01%
- Gilead Sciences Inc — 2.82%
- Thermo Fisher Scientific Inc — 2.52%
- Vertex Pharmaceuticals Inc — 2.28%
- Bristol-myers Squibb Co — 2.11%
- Abbott Laboratories — 1.89%
LHCOX top 10
- Eli Lilly & Co — 10.40%
- UnitedHealth Group Inc — 5.39%
- Johnson & Johnson — 4.96%
- Novartis AG — 4.19%
- Natera Inc — 3.60%
- Gilead Sciences Inc — 3.53%
- CVS Health Corp — 3.33%
- Guardant Health Inc — 2.61%
- Galderma Group AG — 2.60%
- Thermo Fisher Scientific Inc — 2.31%
FAQ
What is the difference between PRHSX and LHCOX?
Which is cheaper, PRHSX or LHCOX?
Should I own both PRHSX and LHCOX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.